2027 ICD-10-CM Diagnosis Code D06.7Carcinoma in situ of other parts of cervix
ICD-10-CM Codes›C00–D49›D00-D09›D06
- Billable — Valid for Submission
- Not Chronic
D06.7 is a billable ICD-10-CM diagnosis code for carcinoma in situ of other parts of cervix. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 731 through 733, 754 through 756. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Female reproductive system cancers - cervix.
Code Identity
Code Classification
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to D06.7: its own notes plus those printed at D06, block D00-D09, and Chapter 2. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- cervical adenocarcinoma in situ
- cervical intraepithelial glandular neoplasia
- cervical intraepithelial neoplasia III [CIN III]
- severe dysplasia of cervix uteri
- Bowen's disease
- erythroplasia
- grade III intraepithelial neoplasia
- Queyrat's erythroplasia
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Notes
General instructions on how these codes are used.
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name D06.7, its category, or a range that includes it.
Applicable To 1
These notes mention D06.7.
Excludes1 10
These codes carry an Excludes1 note naming D06.7: they are not reported together with it, unless the two conditions are unrelated.
- C53 Malignant neoplasm of cervix utericarcinoma in situ of cervix uteri (D06.-) names D06.-, which includes this code
- N87 Dysplasia of cervix utericarcinoma in situ of cervix uteri (D06.-) names D06.-, which includes this code
- N87 Dysplasia of cervix utericervical intraepithelial neoplasia III [CIN III] (D06.-) names D06.-, which includes this code
- N87 Dysplasia of cervix uterisevere dysplasia of cervix uteri (D06.-) names D06.-, which includes this code
- R87.61 Abnormal cytological findings in specimens from cervix utericarcinoma in situ of cervix uteri (histologically confirmed) (D06.-) names D06.-, which includes this code
- R87.61 Abnormal cytological findings in specimens from cervix utericervical intraepithelial neoplasia III [CIN III] (D06.-) names D06.-, which includes this code
- R87.61 Abnormal cytological findings in specimens from cervix uterisevere dysplasia of cervix uteri (histologically confirmed) (D06.-) names D06.-, which includes this code
- R87.7 Abnormal histological findings in specimens from female genital organscervical intraepithelial neoplasia III [CIN III] (D06.-) names D06.-, which includes this code
- R87.7 Abnormal histological findings in specimens from female genital organssevere dysplasia of cervix uteri (histologically confirmed) (D06.-) names D06.-, which includes this code
- R87.7 Abnormal histological findings in specimens from female genital organs
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Carcinoma (malignant) See Also: Neoplasm, by site, malignant;
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| cervix (cervical) (uteri) (uterus) › squamocolumnar junction | C53.8 | C79.82 | D06.7 | D26.0 | D39.0 | D49.59 |
| cervix (cervical) (uteri) (uterus) › stump | C53.8 | C79.82 | D06.7 | D26.0 | D39.0 | D49.59 |
| junction › squamocolumnar, of cervix | C53.8 | C79.82 | D06.7 | D26.0 | D39.0 | D49.59 |
| stump, cervical | C53.8 | C79.82 | D06.7 | D26.0 | D39.0 | D49.59 |
| uterus, uteri, uterine › squamocolumnar junction | C53.8 | C79.82 | D06.7 | D26.0 | D39.0 | D49.59 |
Patient EducationClinical
Cervical Cancer
Cervical cancer is cancer that starts in the cells of the cervix. The cervix is part of the female reproductive system. It is the lower, narrow end of the uterus (womb), which opens into the vagina (birth canal).
The full article covers:
- What is cervical cancer?
- What causes cervical cancer?
- Who is more likely to develop cervical cancer?
- What are the symptoms of cervical cancer?
- How is cervical cancer diagnosed?
- What are the treatments for cervical cancer?
- Can cervical cancer be prevented?
- What is Cervical Cancer?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D06.7 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D06.7Overview
What is the ICD-10 code for carcinoma in situ of other parts of cervix?
The ICD-10-CM code for carcinoma in situ of other parts of cervix is D06.7 (sometimes written as D067). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is D06.7 (Carcinoma in situ of cervix uteri) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report carcinoma in situ of other parts of cervix on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does D06.7 group to?
When carcinoma in situ of other parts of cervix is the principal diagnosis on an inpatient stay, it groups to MS-DRG 732, 755, 756, 754, 733, 731, with relative weights from 0.8583 to 3.5462 depending on complications. Higher weights mean higher Medicare reimbursement.
Can D06.7 be reported with N87.1?
Not as a rule. The Excludes1 note at D06, which applies to D06.7, lists "cervical intraepithelial neoplasia II [CIN II] (N87.1)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
What is the ICD-9 equivalent of D06.7?
Under the General Equivalence Mappings, carcinoma in situ of other parts of cervix converts to ICD-9-CM 233.1 (ca in situ cervix uteri). The mapping is approximate, so confirm the match fits the documentation.
